ALTAMIRA THERAPEUTICS LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.53 USD | +4.08% |
|
-14.04% | -56.03% |
Quotes 5-day view
End-of-day quote Nasdaq| 2024-05-24 | 2024-05-28 | 2024-05-29 | 2024-05-30 | 2024-05-31 | |
|---|---|---|---|---|---|
| Last | 1.78 $ | 1.61 $ | 1.6 $ | 1.47 $ | 1.53 $ |
| Volume | 948 719 | 561 391 | 136 864 | 155 382 | 50 058 |
| Change | +4.09% | -9.55% | -0.62% | -8.13% | +4.08% |
| Opening | 1.70 | 1.65 | 1.67 | 1.53 | 1.49 |
| High | 1.90 | 1.85 | 1.76 | 1.57 | 1.53 |
| Low | 1.63 | 1.59 | 1.52 | 1.45 | 1.48 |
Performance
| 1 day | +4.08% | ||
| 1 week | -14.04% | ||
| 1 month | -5.56% | ||
| 3 months | -37.04% | ||
| 6 months | -76.02% | ||
| Current year | -56.03% | ||
| 1 year | -91.21% | ||
| 3 years | -99.89% | ||
| 5 years | -99.87% |
Volumes
marketsDaily volume
50 058
Avg. Volume 20 sessions
3 594 050
Avg. Volume 20 sessions USD
5 498 896.50
Record volume 1
62 807 935
Record volume 2
51 737 753
Record volume 3
16 486 219
Capital turnover ratio
1.60
Float rotation
1.62
Basic data
Capitalization (USD)
3 427 574
Net sales (CHF)
0
Net sales (USD)
0
Number of employees
10
Sales / Employee (CHF)
0
Sales / Employee (USD)
0
Free-Float
99.11 %
Free-Float capitalization (USD)
3 396 974
Average Daily Capital Traded
177.2%
Highs and lows
1 week
1.45
1.85
1 month
1.402.47
Current year
1.353.60
1 year
1.3517.60
3 years
1.351 832.00
5 years
1.352 640.00
10 years
1.35636 800.00
Indicators
Moving average 5 days
1.60
Moving average 20 days
1.55
Moving average 50 days
1.70
Moving average 100 days
1.86
Price spread / (MMA5)
+4.58%
Price spread / (MMA20)
+1.31%
Price spread / (MMA50)
+11.11%
Price spread / (MMA100)
+21.57%
STIM
RSI 9 days
47.31
RSI 14 days
47.17
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +4.08% | -14.04% | -56.03% | -91.21% | 3.43M | ||
| +1.06% | -0.49% | +11.60% | +34.05% | 106B | ||
| +1.87% | +3.76% | -4.68% | -3.38% | 24.28B | ||
| +1.04% | +0.89% | -0.82% | -6.84% | 21.96B | ||
| +0.31% | +0.55% | -10.12% | -29.18% | 18.16B | ||
| +0.41% | -1.50% | -42.12% | -37.24% | 16.37B | ||
| -3.50% | -2.53% | -17.47% | -33.39% | 15.56B | ||
| -0.91% | -2.86% | +2.77% | +48.49% | 13.63B | ||
| +4.28% | +5.12% | +34.58% | +4.43% | 12.27B | ||
| -3.39% | +150.23% | +77.64% | +186.12% | 8.87B | ||
| -1.71% | +3.60% | +7.26% | +53.59% | 7.75B | ||
| +0.09% | +2.20% | +11.89% | +39.70% | 7.65B | ||
| +0.25% | -1.43% | -3.92% | +25.16% | 7.42B | ||
| -7.66% | -3.38% | -33.51% | -37.11% | 7.29B | ||
| +0.78% | -0.78% | +234.55% | +183.39% | 6.87B | ||
| +4.40% | +5.47% | -9.57% | +11.89% | 6.32B | ||
| Average | +0.09% | +9.10% | +12.63% | +21.78% | ||
| Weighted average by Cap. | +0.41% | +5.04% | +9.01% | +21.58% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -56.03% | ||
| 2023 | -96.41% | ||
| 2022 | -86.64% | ||
| 2021 | -30.73% | ||
| 2020 | +61.73% | ||
| 2019 | -82.24% | ||
| 2018 | -92.28% | ||
| 2017 | -44.81% | ||
| 2016 | -78.12% | ||
| 2015 | +25.38% | ||
| 2014 | -35.00% |
- Stock Market
- Equities
- CYTO Stock
- Quotes Altamira Therapeutics Ltd.
